{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:10:48Z","timestamp":1767474648671,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; objectives<\/jats:title>\n                    <jats:p>Non-small cell lung cancer (NSCLC) represents a malignant neoplasm exhibiting high incidence and mortality rates, marked by diminished patient survival probabilities and an unfavorable prognosis. The primary objective of this research is to investigate the prognostic value of miR-4701-3p in NSCLC and its regulatory role in tumor progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, a cohort comprising 105 patients with NSCLC was enrolled. Expression levels of miR-4701-3p in tissues and cell lines were assayed using RT-qPCR. To investigate the correlation between miR-4701-3p and clinicopathological features, the \u03c72 test was applied. Additionally, Kaplan-Meier survival analysis alongside Cox regression modeling were performed to evaluate the prognostic significance of miR-4701-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>miR-4701-3p was markedly upregulated in NSCLC tissues and cells. miR-4701-3p was significantly correlated with TNM stage and lymph node metastasis (LNM) in NSCLC patients. The group exhibiting high miR-4701-3p expression demonstrated a markedly decreased 5-year survival rate in comparison to the low expression group. According to Cox regression analysis, miR-4701-3p expression, TNM stage, and lymph node metastasis (LNM) emerged as independent predictors of the 5-year survival rate among NSCLC patients. By downregulating miR-4701-3p, a substantial inhibition of NSCLC cell proliferation, migration, and invasion was observed, accompanied by enhanced apoptotic activity. Conversely, overexpressing miR-4701-3p can enhance cell proliferation, invasion, and migration abilities while inhibiting cell apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The elevated expression of miR-4701-3p in NSCLC tissues has certain predictive value for poor prognosis in patients and may be involved in malignant behaviors of NSCLC cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00612-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:17:40Z","timestamp":1764317860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-4701-3p predicts prognosis of non-small cell lung cancer and regulates cell biological behaviors"],"prefix":"10.1186","volume":"163","author":[{"given":"Zhenhua","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangtao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"3","key":"612_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7689","key":"612_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"17","key":"612_CR3","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1111\/1759-7714.14562","volume":"13","author":"ZY Chen","year":"2022","unstructured":"Chen ZY, Fu R, Tan XY, Yan LX, Tang WF, Qiu ZB, et al. Dynamic (18) F-FDG PET\/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer. Thorac Cancer. 2022;13(17):2524\u201331.","journal-title":"Thorac Cancer"},{"issue":"1","key":"612_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00933-0","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Lei Y, Chen W, Zhou Q, Zheng Z, Zeng G, et al. In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-\u03baB modulator in lung cancer. Cell Biosci. 2022;12(1):193.","journal-title":"Cell Biosci"},{"issue":"5","key":"612_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843\u201354.","journal-title":"Cell"},{"issue":"22","key":"612_CR6","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.7314\/APJCP.2014.15.22.9557","volume":"15","author":"MR Aghanoori","year":"2014","unstructured":"Aghanoori MR, Mirzaei B, Tavallaei M. MiRNA molecular profiles in human medical conditions: connecting lung cancer and lung development phenomena. Asian Pac J Cancer Prev. 2014;15(22):9557\u201365.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"24","key":"612_CR7","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"612_CR8","doi-asserted-by":"crossref","unstructured":"Wu KL, Tsai YM, Lien CT, Kuo PL, Hung AJ. The Roles of MicroRNA in Lung Cancer. International journal of molecular sciences. 2019;20(7):1611.","DOI":"10.3390\/ijms20071611"},{"issue":"9","key":"612_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23003","volume":"33","author":"Q He","year":"2019","unstructured":"He Q, Fang Y, Lu F, Pan J, Wang L, Gong W, et al. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer. J Clin Lab Anal. 2019;33(9):e23003.","journal-title":"J Clin Lab Anal"},{"key":"612_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01320","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Ma Y, Lin Y, Chen R, Xu B, Deng J. SHU00238 promotes colorectal cancer cell apoptosis through miR-4701-3p and miR-4793-3p. Front Genet. 2019;10:1320.","journal-title":"Front Genet"},{"issue":"3","key":"612_CR11","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3390\/cimb46030171","volume":"46","author":"A Kokot","year":"2024","unstructured":"Kokot A, Gadakh S, Saha I, Gajda E, \u0141a\u017aniewski M, Rakshit S, et al. Unveiling the molecular mechanism of trastuzumab resistance in SKBR3 and BT474 cell lines for HER2 positive breast cancer. Curr Issues Mol Biol. 2024;46(3):2713\u201340.","journal-title":"Curr Issues Mol Biol"},{"key":"612_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","volume":"6","author":"G da Cunha Santos","year":"2011","unstructured":"da Cunha Santos G, Shepherd FA, Tsao MS. EGFR mutations and lung cancer. Annu Rev Pathol. 2011;6:49\u201369.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"612_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01044-3","volume":"28","author":"Z Fu","year":"2023","unstructured":"Fu Z, Li D, Deng C, Zhang J, Bai J, Li Y, et al. Excellent survival of pathological N0 small cell lung cancer patients following surgery. Eur J Med Res. 2023;28(1):91.","journal-title":"Eur J Med Res"},{"issue":"9","key":"612_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cancergen.2011.07.004","volume":"204","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Liu S, Shi R, Zhao G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet. 2011;204(9):486\u201391.","journal-title":"Cancer Genet"},{"key":"612_CR15","doi-asserted-by":"crossref","unstructured":"Wang YL, Gong WG, Yuan QL. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis. Genetics and molecular research: GMR. 2016;15(4):gmr15049070.","DOI":"10.4238\/gmr15049070"},{"issue":"4","key":"612_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.sjbs.2018.12.009","volume":"26","author":"S Wang","year":"2019","unstructured":"Wang S, Wang Z, Wang Q, Cui Y, Luo S. Clinical significance of the expression of miRNA-21, miRNA-31 and miRNA-let7 in patients with lung cancer. Saudi J Biol Sci. 2019;26(4):777\u201381.","journal-title":"Saudi J Biol Sci"},{"key":"612_CR17","doi-asserted-by":"crossref","unstructured":"Ren S, Rivard CJ, Yu H, Genova C, Rozenboom L, Gao D, et al. A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines. Clinical lung cancer. 2018;19(5):450\u20136.","DOI":"10.1016\/j.cllc.2018.06.004"},{"issue":"14","key":"612_CR18","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2217\/fon.14.93","volume":"10","author":"M Us\u00f3","year":"2014","unstructured":"Us\u00f3 M, Jantus-Lewintre E, Sirera R, Bremnes RM, Camps C. miRNA detection methods and clinical implications in lung cancer. Future Oncol. 2014;10(14):2279\u201392.","journal-title":"Future Oncol"},{"issue":"9","key":"612_CR19","doi-asserted-by":"publisher","first-page":"15170","DOI":"10.1002\/jcb.28779","volume":"120","author":"Y Wang","year":"2019","unstructured":"Wang Y, Luo X, Liu Y, Han G, Sun D. Long noncoding RNA RMRP promotes proliferation and invasion via targeting miR-1-3p in non-small-cell lung cancer. J Cell Biochem. 2019;120(9):15170\u201381.","journal-title":"J Cell Biochem"},{"issue":"10","key":"612_CR20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00432-012-1240-0","volume":"138","author":"YK Zhang","year":"2012","unstructured":"Zhang YK, Zhu WY, He JY, Chen DD, Huang YY, Le HB, et al. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. J Cancer Res Clin Oncol. 2012;138(10):1641\u201350.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"612_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1620\/tjem.232.85","volume":"232","author":"C Wu","year":"2014","unstructured":"Wu C, Cao Y, He Z, He J, Hu C, Duan H, et al. Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer. Tohoku J Exp Med. 2014;232(2):85\u201395.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"612_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054596","volume":"8","author":"C Sanfiorenzo","year":"2013","unstructured":"Sanfiorenzo C, Ilie MI, Belaid A, Barl\u00e9si F, Mouroux J, Marquette CH, et al. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One. 2013;8(1):e54596.","journal-title":"PLoS One"},{"issue":"1","key":"612_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5048-4","volume":"18","author":"C Fortea-Sanchis","year":"2018","unstructured":"Fortea-Sanchis C, Mart\u00ednez-Ramos D, Escrig-Sos J. The lymph node status as a prognostic factor in colon cancer: comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems. BMC Cancer. 2018;18(1):1208.","journal-title":"BMC Cancer"},{"issue":"1","key":"612_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jjco\/hyz120","volume":"50","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lin Z, Lyu M, Chen N, Liao H, Wang Z, et al. Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol. 2020;50(1):44\u201357.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"612_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2006.09.009","volume":"11","author":"WP Kloosterman","year":"2006","unstructured":"Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441\u201350.","journal-title":"Dev Cell"},{"issue":"1","key":"612_CR26","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"612_CR27","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1002\/jcb.28345","volume":"120","author":"G Li","year":"2019","unstructured":"Li G, Wang K, Wang J, Qin S, Sun X, Ren H. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer. J Cell Biochem. 2019;120(6):10587\u201395.","journal-title":"J Cell Biochem"},{"key":"612_CR28","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2147\/CMAR.S181058","volume":"11","author":"W Wei","year":"2019","unstructured":"Wei W, Huo B, Shi X. MiR-600 inhibits lung cancer via downregulating the expression of METTL3. Cancer Manag Res. 2019;11:1177\u201387.","journal-title":"Cancer Manag Res"},{"key":"612_CR29","doi-asserted-by":"crossref","unstructured":"Lee SM, Yoon BH, Lee JW, Jeong IJ-Y, Kim I, Pack C-G, et al. Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Microvascular research. 2024;155:104698.","DOI":"10.1016\/j.mvr.2024.104698"},{"issue":"1","key":"612_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48961-1","volume":"13","author":"S Zhang","year":"2023","unstructured":"Zhang S, Gu J, Shi L-L, Qian B, Diao X, Jiang X, et al. A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer. Sci Rep. 2023;13(1):21607.","journal-title":"Sci Rep"},{"issue":"3","key":"612_CR31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12094-022-02984-8","volume":"25","author":"N Bao","year":"2022","unstructured":"Bao N, Zhang P, Zhu Y, Du P, Jin G, Wu B, et al. MiR-378a-3p promotes renal cell carcinoma proliferation, migration, and invasion by targeting TOB2. Clin Transl Oncol. 2022;25(3):748\u201357.","journal-title":"Clin Transl Oncol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00612-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00612-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00612-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:04:45Z","timestamp":1767474285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00612-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00612-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"type":"electronic","value":"1601-5223"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have obtained First Medical Center of Chinese PLA General Hospital review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}